Top Stories
The proposals call for staged authorisations, continuous monitoring and greater transparency as AI becomes more widely used across the NHS.
The funding follows FDA clearance for its implantable monitor ECG analyser, which Implicity says can cut false-positive episodes by up to 76%.
The agency is working with the FDA on evaluation standards and ongoing safety monitoring for autonomous clinical AI, with the first authorisation packages due within two years.
Brainomix's 360 E-lung software found that patients treated with taladegib had "significant positive differences" in lung volume, overall interstitial lung disease burden and total fibrosis extent.
The series C round comes just months after the healthcare automation startup raised more than $160 million.
Conference News
New findings support the applicability of PROphetNSCLC® following chemo or immunotherapy-based cycle, potentially broadening its real-world clinical utilityBINYAMINA, Israel and CARY, N.C., Sept. 10, ...
Targets $36 Billion TAM in Early Cancer Detection and MRD.HENDERSON, Nev., Sept. 10, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, a...
Each Screen Failure Has a Story. Carebox Is Helping Clinical Trial Sponsors Read It.The patients who don't make it to a trial are trying to tell you something. Most recruitment programs aren't set up ...
A new initiative to connect and empower early-career pathologists across EuropeSakura Finetek Europe today announced the launch of the Sakura Pathology Network (SPN), a new European network bringing t...
Research highlights the significance of genomic and epigenomic profiling approaches to characterize lung tumors, identify biomarkers, and support risk stratificationReal-world studies examine the comp...
